Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Pharmacodynamics, Pharmacogenomics, and Preliminary Safety and Efficacy of Alemtuzumab Induction and Tacrolimus in Pediatric Intestinal Transplantation (IND # 100496)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01208337
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:17.262161+00:00
Published At
2016-06-20T00:00:00+00:00
Record Updated At
2023-03-08
Results Posted At
2016-06-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Evidence of Liver Transplantation", "Rejection", "ALEMTUZUMAB"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-08"
protocolSection.identificationModule.nctId
"NCT01208337"
protocolSection.identificationModule.officialTitle
"Pharmacodynamics, Pharmacogenomics, and Preliminary Safety and Efficacy of Alemtuzumab Induction and Tacrolimus in Pediatric Intestinal Transplantation (IND # 100496)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-06-20"

Study condition terms

  • Evidence of Liver Transplantation (protocolSection.conditionsModule.conditions)
  • Rejection (protocolSection.conditionsModule.conditions)
  • ALEMTUZUMAB (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.